Cite
HARVARD Citation
Shmidt, E. et al. (2018). Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease. Inflammatory bowel diseases. 24 (11), pp. 2461-2467. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shmidt, E. et al. (2018). Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease. Inflammatory bowel diseases. 24 (11), pp. 2461-2467. [Online].